Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Lung Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06219317
What this trial is testing

Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC

Who this might be right for
NSCLC Stage IV
European Organisation for Research and Treatment of Cancer - EORTC 136
Not applicableActive Not RecruitingNCT02417662
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University College, London 140
Testing effectiveness (Phase 2)Ended earlyNCT05846646
What this trial is testing

Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC

Who this might be right for
Oligometastatic Disease
ImmuneSensor Therapeutics Inc. 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Large-scale testing (Phase 3)Looking for participantsNCT07738172
What this trial is testing

Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Neoplasms, Non-Small Cell Lung Cancer
National Taiwan University Hospital 154
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07410611
What this trial is testing

CtDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy

Who this might be right for
Patients With Advanced Oligometastatic Non-small Cell Lung Cancer (NSCLC) Who Have Tested Positive for EGFR Mutations Confirmed by Histopathological Examination
Hebei Medical University Fourth Hospital 84
Not applicableStudy completedNCT06236516
What this trial is testing

One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors

Who this might be right for
Lung CancerOligometastatic Lung Tumor
Washington University School of Medicine 10
Testing effectiveness (Phase 2)UnknownNCT01796288
What this trial is testing

The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment

Who this might be right for
Non Small Cell Lung Cancer, Oligometastatic
Wu Jieping Medical Foundation 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07333651
What this trial is testing

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Who this might be right for
Oligometastatic Disease
Li Min 90
Not applicableUnknownNCT06207292
What this trial is testing

Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer

Who this might be right for
NSCLCNSCLC Stage IVOligometastatic Disease+9 more
Radiotherapy Oncology Centre "Santa Maria" Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT06141070
What this trial is testing

Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease

Who this might be right for
Non Small Cell Lung Cancer
Vastra Gotaland Region 240
Large-scale testing (Phase 3)UnknownNCT02076477
What this trial is testing

The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）

Who this might be right for
Oligo-metastatic Stage IV Non-small Cell Lung Cancer
Sichuan Cancer Hospital and Research Institute 420
Early research (Phase 1)Ended earlyNCT03275597
What this trial is testing

Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition

Who this might be right for
Non-small Cell Lung CancerNon-small Cell Lung Cancer Stage IV
University of Wisconsin, Madison 17
Testing effectiveness (Phase 2)Looking for participantsNCT05837052
What this trial is testing

A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC

Who this might be right for
Unresectable Lung Non-Small Cell Carcinoma
Zhejiang University 49
Testing effectiveness (Phase 2)Looking for participantsNCT04375904
What this trial is testing

'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)

Who this might be right for
NSCLC/Oligometastatic Cancer (Single Lung Lesion)
Cancer Trials Ireland 68
Testing effectiveness (Phase 2)Looking for participantsNCT05501665
What this trial is testing

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage III Lung Cancer
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT05277844
What this trial is testing

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

Who this might be right for
Oligometastatic DiseaseNon-small Cell Lung CancerDriver Mutation
Tata Memorial Hospital 106
Testing effectiveness (Phase 2)Study completedNCT02107755
What this trial is testing

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

Who this might be right for
Liver MetastasesLung MetastasesRecurrent Melanoma+2 more
Ohio State University Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT02316002
What this trial is testing

Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Abramson Cancer Center at Penn Medicine 51
Not applicableStudy completedNCT02450591
What this trial is testing

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Who this might be right for
Oligometastatic Lung Adenocarcinoma
Memorial Sloan Kettering Cancer Center 4
Next Page